Patent directory Β· USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code β or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 12226435
Bispecific OR-gate chimeric antigen receptor responsive to CD20 and CD19
granted -
US 12226546
Polyion complex polypeptide hydrogels and uses thereof
granted -
US 12226423
Compositions comprising 5-cholesten-3, 25-diol, 3-sulfate (25HC3S) or pharmaceutically acceptable salt thereof and at least one cyclic oligosaccharide
granted -
US 12226476
Helper epitope peptide and application thereof
granted -
US 12226412
Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators
granted -
US 12227547
Modulators of CAS9 polypeptides and methods of use thereof
granted -
US 12226373
Treatment of fragile X syndrome with cannabidiol
granted -
US 12226386
Compositions and methods for treating biofilms
granted -
US 12226417
Fatty liver disease treatment using glucocorticoid and mineralocorticoid receptor antagonists
granted -
US 12226425
Inhibitors of ARG1 and/or ARG2
granted -
US 12226524
Coated implants for long-term controlled release of antibody therapeutics
granted -
US 12226410
Methods for enhancing cellular clearance of pathological molecules via activation of the cellular protein ykt6
granted -
US 12226456
Nasal powder formulation for treatment of hypoglycemia
granted -
US 12226429
Highly active compounds against COVID-19
granted -
US 12226491
Nano-satellite complexes
granted -
US 12227482
Compounds and compositions for the treatment of cancer
granted -
US 12227508
TGF-Ξ² inhibitors
granted -
US 12230378
Systems and methods for coordinating manufacturing of cells for patient-specific immunotherapy
granted -
US 12230364
Immunotherapy methods for patients whose tumors carry a high passenger gene mutation burden
granted -
US 12226450
Peptides and methods for treating disease
granted -
US 12227584
Multivalent and multispecific OX40-binding fusion proteins
granted -
US 12227504
Spirocyclic compounds
granted -
US 12227580
Antigen binding molecules that bind LIGHT
granted -
US 12227581
Anti-BCMA single domain antibodies and application thereof
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search β best for looking up a specific filing or applicant portfolio slice.